Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MS › Columbus › NPI 1609830173
Transport

Baptist Memorial Hospital - Golden Triangle INC.

Baptist Memorial Hospital - Golden Triangle INC. was paid $56.02M by Medicaid between Jan 2018 and Dec 2024, across 366 billing codes. Its largest line is 99284, emergency room visit (serious) — 16% of everything it billed.

33Billing provider infoBAPTIST MEMORIAL HOSPITAL - GOLDEN TRIANGLE INC.
COLUMBUS, MS 39705
33aNPI1609830173assigned 04/13/2006
33bProvider typeAmbulance
28Total paid$56.02M
24GClaims1,817,043
24DCodes billed366
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Ambulance providers in Mississippi

Rank by total paid#1 of 22
Median peer was paid$597K
This provider vs. median94×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official DUCKETT, GREGORY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018240,350$7.89M
2019243,024$8.44M
2020214,503$6.63M
2021285,422$7.78M
2022322,493$8.64M
2023287,011$9.55M
2024incomplete224,240$7.09M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 16% 53,084 41,636 $8.88M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 12% 50,758 41,554 $6.46M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 9.4% 31,300 23,972 $5.25M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.4% 27,086 19,553 $1.90M
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3.1% 48,168 34,488 $1.75M
A0429 Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) 2.6% 12,871 8,322 $1.46M
A0425 Ground mileage, per statute mile 2.3% 18,638 11,492 $1.28M
G0378 Hospital observation service, per hour 2.2% 3,481 2,316 $1.26M
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.2% 15,178 13,043 $1.23M
71045 Radiologic examination, chest; single view 2.1% 32,061 24,378 $1.16M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.0% 9,376 7,285 $1.12M
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1.8% 10,734 7,537 $1.04M
354 more codes
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1.8% 9,001 $991K
A0427 Emergency ambulance ride, advanced life support 1.7% 10,835 $945K
J9271 Injection, pembrolizumab, 1 mg 1.3% 212 $705K
96375 Therapeutic injection; each additional sequential IV push 1.2% 29,033 $679K
J0897 Injection, denosumab, 1 mg 1.2% 1,603 $664K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.1% 9,173 $644K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.1% 13,125 $634K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.1% 4,279 $628K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1.1% 53,612 $607K
80053 Comprehensive metabolic panel 1.1% 96,800 $590K
96361 Intravenous infusion, hydration; each additional hour 1.0% 16,770 $588K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 33,890 $526K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 16,483 $507K
78815 Positron emission tomography (PET) for limited area imaging <1% 1,413 $462K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 100,754 $435K
70450 Computed tomography, head or brain; without contrast material <1% 9,738 $418K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 16,953 $413K
J2357 Injection, omalizumab, 5 mg <1% 717 $403K
71046 Radiologic examination, chest; 2 views <1% 10,664 $399K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 12,774 $395K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 10,264 $363K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 7,883 $340K
93458 <1% 384 $335K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 4,367 $327K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 23,337 $325K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 9,788 $318K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 4,897 $284K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 7,339 $274K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 4,642 $271K
J2505 Injection, pegfilgrastim, 6 mg <1% 142 $262K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 853 $260K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 3,201 $256K
36415 Collection of venous blood by venipuncture <1% 118,948 $248K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 3,791 $235K
D7140 Extraction, erupted tooth or exposed root <1% 725 $231K
99214 Doctor's office visit, returning patient (more involved) <1% 9,887 $214K
D0272 Bitewings - two radiographic images <1% 352 $208K
36902 <1% 214 $196K
86900 <1% 4,788 $194K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,691 $193K
36430 <1% 1,972 $180K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 4,218 $172K
84484 <1% 23,772 $158K
76801 <1% 2,034 $137K
72100 <1% 2,963 $132K
J2469 Injection, palonosetron hcl, 25 mcg <1% 4,267 $132K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 10,412 $131K
99223 Prolong inpt eval add15 m <1% 1,931 $127K
P9016 Red blood cells, leukocytes reduced, each unit <1% 1,936 $120K
73560 <1% 3,472 $117K
99232 Hospital visit by a doctor, follow-up day <1% 5,018 $117K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,737 $112K
81001 <1% 47,760 $106K
D2930 Prefabricated stainless steel crown - primary tooth <1% 1,811 $106K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 15,594 $95K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 9,314 $93K
83735 <1% 25,915 $87K
A0428 Ambulance service, basic life support, non-emergency transport, (bls) <1% 3,663 $85K
83880 <1% 4,562 $84K
94726 <1% 1,193 $79K
73630 <1% 2,032 $78K
36600 <1% 3,038 $78K
86850 <1% 4,139 $77K
73610 <1% 1,868 $77K
99213 Doctor's office visit, returning patient (routine) <1% 5,190 $76K
84443 Thyroid stimulating hormone (TSH) <1% 8,365 $76K
73030 <1% 2,271 $75K
74018 <1% 1,669 $73K
47562 <1% 30 $73K
85027 <1% 19,157 $72K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 28,093 $72K
93017 <1% 1,202 $72K
93971 <1% 2,107 $71K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 1,138 $71K
87807 <1% 6,937 $71K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,394 $70K
95811 <1% 209 $69K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 203 $69K
87086 Culture, bacterial; quantitative colony count, urine <1% 13,371 $67K
96367 <1% 2,710 $66K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,854 $65K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,855 $65K
83690 <1% 15,104 $63K
73130 <1% 1,572 $59K
86901 <1% 4,788 $58K
A0380 Bls mileage (per mile) <1% 135 $57K
71250 <1% 1,821 $56K
80048 Basic metabolic panel (calcium, ionized) <1% 10,373 $54K
86923 <1% 1,464 $51K
80061 Lipid panel <1% 5,878 $50K
83605 <1% 9,319 $50K
72125 Computed tomography, cervical spine; without contrast material <1% 1,483 $49K
87040 <1% 8,462 $46K
81025 <1% 8,143 $44K
82803 <1% 3,079 $42K
73502 <1% 1,532 $42K
94060 <1% 481 $41K
93798 <1% 1,819 $40K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 4,174 $40K
96417 <1% 1,509 $40K
84702 <1% 3,848 $40K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 791 $38K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 29 $38K
77067 Screening mammography, bilateral, including computer-aided detection <1% 576 $36K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,643 $36K
J0185 Injection, aprepitant, 1 mg <1% 509 $36K
86300 <1% 4,658 $35K
82728 <1% 6,241 $34K
10060 <1% 372 $34K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 2,090 $33K
97161 <1% 1,084 $32K
73110 <1% 818 $31K
Q3014 Telehealth originating site facility fee <1% 1,892 $30K
72040 <1% 899 $30K
77300 <1% 100 $29K
A9270 Non-covered item or service <1% 12,804 $28K
96523 <1% 1,535 $28K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 223 $27K
84703 <1% 5,105 $26K
83036 Hemoglobin; glycosylated (A1C) <1% 4,662 $26K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 307 $26K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,476 $25K
93925 <1% 436 $24K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,241 $23K
82375 <1% 2,905 $21K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 372 $20K
85007 <1% 8,081 $20K
85610 <1% 8,711 $20K
J2997 Injection, alteplase recombinant, 1 mg <1% 183 $19K
96411 <1% 779 $18K
70486 <1% 403 $18K
82150 <1% 3,811 $18K
83550 <1% 5,537 $16K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 899 $16K
84439 <1% 3,411 $16K
99239 Hospital discharge day management, more than 30 minutes <1% 437 $15K
82607 <1% 2,370 $15K
85379 <1% 2,729 $15K
77336 <1% 248 $14K
86140 <1% 4,934 $14K
97116 <1% 1,276 $13K
70491 <1% 187 $13K
83050 <1% 2,893 $13K
83540 <1% 5,550 $12K
87070 <1% 2,235 $12K
93970 <1% 189 $12K
82378 <1% 2,019 $12K
85730 <1% 3,060 $10K
80069 <1% 3,041 $10K
93922 <1% 259 $10K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 64 $9K
99215 Doctor's office visit, returning patient (complex) <1% 196 $9K
75716 <1% 14 $9K
74178 <1% 84 $8K
83615 <1% 2,634 $7K
93880 <1% 132 $7K
82550 <1% 2,093 $7K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 39 $7K
82746 <1% 1,306 $7K
73140 <1% 167 $6K
87205 <1% 2,271 $6K
84550 <1% 2,325 $6K
82570 <1% 2,074 $6K
85045 <1% 2,969 $6K
85652 <1% 4,132 $6K
73080 <1% 152 $6K
76000 <1% 39 $5K
70498 <1% 138 $5K
72131 <1% 158 $5K
82784 <1% 2,535 $5K
82565 <1% 2,395 $5K
99238 Hospital discharge day management, 30 minutes or less <1% 271 $5K
84153 <1% 926 $5K
73590 <1% 112 $5K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 447 $5K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 298 $5K
80164 <1% 544 $4K
J2800 Injection, methocarbamol, up to 10 ml <1% 889 $4K
80074 <1% 231 $4K
J7030 Infusion, normal saline solution , 1000 cc <1% 24,541 $4K
97162 <1% 111 $4K
87210 <1% 1,129 $4K
82043 <1% 1,145 $4K
72070 <1% 59 $4K
94010 <1% 66 $4K
G0008 Administration of influenza virus vaccine <1% 257 $3K
83883 <1% 1,005 $3K
76642 <1% 86 $3K
77065 Tomosynthesis, mammo <1% 74 $3K
78227 <1% 13 $3K
J7050 Infusion, normal saline solution, 250 cc <1% 13,311 $3K
D1120 Dental cleaning, child <1% 395 $3K
70496 <1% 64 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 19,232 $3K
12001 <1% 28 $3K
D1208 Topical application of fluoride, excluding varnish <1% 68 $3K
84165 <1% 1,125 $2K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring <1% 25 $2K
92523 <1% 32 $2K
73090 <1% 64 $2K
76775 <1% 52 $2K
D1206 Topical application of fluoride varnish <1% 357 $2K
41899 Unlisted procedure, dentoalveolar structures <1% 14 $2K
90686 <1% 284 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 10,850 $2K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 1,182 $2K
99204 Doctor's office visit, new patient (more involved) <1% 55 $2K
36589 <1% 13 $2K
36416 <1% 695 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 28,258 $1K
96415 <1% 32 $1K
84156 <1% 590 $1K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 17 $1K
86803 <1% 167 $1K
96416 <1% 20 $1K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 4,752 $1K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 21 $1K
76770 <1% 15 $1K
83970 <1% 60 $1K
74019 <1% 13 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 12,431 $1K
84480 <1% 90 $997.36
86003 <1% 623 $951.52
84100 <1% 500 $947.71
J8540 Dexamethasone, oral, 0.25 mg <1% 712 $930.30
82009 <1% 407 $929.98
J0640 Injection, leucovorin calcium, per 50 mg <1% 280 $913.59
A0426 Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) <1% 173 $846.69
36591 <1% 391 $716.38
80177 <1% 76 $667.12
83516 <1% 186 $663.78
C1769 Guide wire <1% 4,563 $660.49
86480 <1% 31 $631.02
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 8,187 $608.12
76536 <1% 13 $598.58
J7120 Ringers lactate infusion, up to 1000 cc <1% 5,720 $591.07
74022 <1% 15 $580.97
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 20,128 $579.23
85014 <1% 321 $554.97
76830 Ultrasound, transvaginal <1% 12 $529.71
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 1,298 $508.27
J2780 Injection, ranitidine hydrochloride, 25 mg <1% 190 $484.76
J2550 Injection, promethazine hcl, up to 50 mg <1% 8,769 $474.89
86038 <1% 90 $464.82
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 3,830 $459.62
96377 <1% 111 $454.56
D0230 Intraoral - periapical each additional radiographic image <1% 832 $433.24
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,373 $410.22
C1760 Closure device, vascular (implantable/insertable) <1% 212 $399.05
J3010 Injection, fentanyl citrate, 0.1 mg <1% 10,638 $388.22
0012A <1% 17 $387.65
J9190 Injection, fluorouracil, 500 mg <1% 326 $358.18
J2270 Injection, morphine sulfate, up to 10 mg <1% 13,508 $350.63
85018 <1% 220 $350.02
96376 <1% 5,314 $340.35
0004A <1% 16 $335.13
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 29 $313.81
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 12,917 $305.24
82785 <1% 29 $290.84
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 920 $288.95
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 2,933 $275.80
83695 <1% 54 $271.73
82272 <1% 99 $266.83
0011A <1% 25 $259.94
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 1,930 $257.52
82085 <1% 56 $237.94
87046 <1% 12 $219.88
87427 <1% 18 $218.96
D0220 Intraoral - periapical first radiographic image <1% 400 $217.14
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 254 $209.86
85384 <1% 34 $195.10
80076 <1% 31 $189.35
84681 <1% 16 $179.85
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 504 $178.66
83655 <1% 13 $175.76
82553 <1% 23 $173.77
86200 <1% 25 $140.52
86160 <1% 26 $130.48
85347 <1% 38 $120.28
87045 <1% 12 $114.69
83525 <1% 14 $98.81
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 20,295 $93.08
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 409 $92.98
86060 <1% 12 $89.93
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 5,179 $82.70
G0379 Direct admission of patient for hospital observation care <1% 13 $82.68
86308 <1% 17 $62.60
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 992 $53.53
84132 <1% 13 $50.09
J1170 Injection, hydromorphone, up to 4 mg <1% 6,067 $49.32
J0690 Injection, cefazolin sodium, 500 mg <1% 5,594 $44.15
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 1,034 $36.84
J2704 Injection, propofol, 10 mg <1% 7,006 $33.32
J2060 Injection, lorazepam, 2 mg <1% 2,141 $23.30
J1644 Injection, heparin sodium, per 1000 units <1% 7,814 $22.95
83521 <1% 1,131 $22.18
C9113 Injection, pantoprazole sodium, per vial <1% 1,640 $15.97
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,764 $12.80
J1030 Injection, methylprednisolone acetate, 40 mg <1% 1,525 $12.28
94729 <1% 1,205 $11.79
J3370 Injection, vancomycin hcl, 500 mg <1% 1,350 $10.50
J0780 Injection, prochlorperazine, up to 10 mg <1% 2,020 $8.94
J3480 Injection, potassium chloride, per 2 meq <1% 89 $7.86
J1940 Injection, furosemide, up to 20 mg <1% 2,290 $6.76
77063 Screening digital breast tomosynthesis, bilateral <1% 243 $6.03
J1790 Injection, droperidol, up to 5 mg <1% 556 $4.07
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries <1% 15 $1.91
J7060 5% dextrose/water (500 ml = 1 unit) <1% 283 $1.71
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg <1% 50 $0.89
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 1,974 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 1,263 $0.00
94760 0% 230 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 507 $0.00
J0592 Injection, buprenorphine hydrochloride, 0.1 mg 0% 675 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 0% 76 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 1,433 $0.00
36410 0% 13 $0.00
96368 0% 662 $0.00
A0888 Noncovered ambulance mileage, per mile (e.g., for miles traveled beyond closest appropriate facility) 0% 2,864 $0.00
77001 0% 428 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 946 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 941 $0.00
A9609 Fludeoxyglucose f18 up to 15 millicuries 0% 207 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 343 $0.00
C1750 Catheter, hemodialysis/peritoneal, long-term 0% 81 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 31 $0.00
J2805 Injection, sincalide, 5 micrograms 0% 12 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 733 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 413 $0.00
J3490 Unclassified drugs 0% 125 $0.00
J3411 Injection, thiamine hcl, 100 mg 0% 30 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 27 $0.00
99205 Prolong outpt/office vis 0% 16 $0.00
J0456 Injection, azithromycin, 500 mg 0% 33 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 853 $0.00
J0595 Injection, butorphanol tartrate, 1 mg 0% 33 $0.00
J1953 Injection, levetiracetam, 10 mg 0% 451 $0.00
J2300 Injection, nalbuphine hydrochloride, per 10 mg 0% 282 $0.00
90715 0% 629 $0.00
J7510 Prednisolone oral, per 5 mg 0% 901 $0.00
84145 0% 640 $0.00
C1788 Port, indwelling (implantable) 0% 476 $0.00
76937 0% 415 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 563 $0.00
J1956 Injection, levofloxacin, 250 mg 0% 65 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 67 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 128 $0.00
C1874 Stent, coated/covered, with delivery system 0% 59 $0.00
C1729 Catheter, drainage 0% 40 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 102 $0.00
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries 0% 13 $0.00
J1643 Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units 0% 128 $0.00
J1580 Injection, garamycin, gentamicin, up to 80 mg 0% 21 $0.00
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDUCKETT, GREGORY (SR VP/ CLO)
Parent organizationBAPTIST MEMORIAL HEALTH CARE CORP.
Same official

Other billing entities under DUCKETT, GREGORY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.